UFP Technologies to Report Q1 Results on May 4

Written by Emily J. Thompson, Senior Investment Analyst

Source: Newsfilter

Updated: 6 days ago

0mins

UFPT+10.32%

Should l Buy UFPT?

Source: Newsfilter

Earnings Report Schedule: UFP Technologies plans to release its Q1 earnings report on May 4, 2026, after market close, reflecting the company's ongoing commitment to transparency in the medical device sector.
Conference Call Timing: The company will hold a conference call on May 5, 2026, at 8:30 AM Eastern Time to discuss the earnings details and address investor inquiries, enhancing engagement with stakeholders.
Participation Details: Investors can join the call using the toll-free number 1-412-206-6478 for USA/Canada or 1-833-890-4010 for international participants, ensuring broad access to the discussion and information dissemination.
Webcast and Replay Availability: A live webcast of the conference call will be available, with accompanying materials posted online, and a replay will be accessible on the company's Investor Relations website, further improving information accessibility and transparency.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy UFPT?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on UFPT

About UFPT

UFP Technologies, Inc. is a designer and custom manufacturer of solutions for medical devices, sterile packaging, and other engineered custom products. The Company’s single-use and single-patient devices and components are used in a range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants. Its manufacturing operations consist primarily of cutting, routing, compression and injection molding, vacuum-forming, micro-molding, thermoforming, laminating, radio frequency and impulse welding, and assembling. It also engineers components for automotive use in interior trim and structural applications. These components are produced using a compression molding process to create functional composites consisting of various materials such as polypropylene/fiberglass panels, nonwovens, and fabrics. It also develops and manufactures precision thermo-formed and heat-sealed polymer components.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

UFP Technologies Reports Q1 Adjusted EPS of $2.48, Exceeding IBES Estimate of $2.25

2 days agomoomoo

Q1 Adjusted EPS: The adjusted earnings per share (EPS) for Q1 is reported at USD 2.48.
IBES Estimate: This figure exceeds the IBES estimate, which was USD 2.25.

UFP Technologies Q1 2026 Earnings Call Insights

2 days agoseekingalpha

Revenue Growth: UFP Technologies reported a 4.1% revenue increase in Q1 2026, with medical sales up 5.9% while non-medical sales declined by 15%, indicating a strategic focus on high-growth segments in the MedTech space amidst shifting market demands.
New Program Developments: The company successfully launched four new programs, with three customers requesting to double their capacity, suggesting strong market demand and the potential for robust revenue growth in the second half of the year.
Cost and Profitability Pressures: Although gross margin improved slightly to 28.8%, profitability was pressured by startup costs, AJR labor inefficiencies, and legal expenses related to a cyberattack, highlighting challenges faced during the expansion phase.
Future Outlook: Management anticipates accelerated revenue growth in the second half of the year, particularly driven by new programs, while also planning to expand capacity in the APAC region to meet future market demands.

UFP Technologies Q1 Earnings Beat Expectations

2 days agoseekingalpha

Earnings Beat: UFP Technologies reported a Q1 non-GAAP EPS of $2.48, exceeding expectations by $0.17, indicating enhanced profitability that may attract more investor interest.
Revenue Miss: The company's revenue of $154.2 million, while up 4.1% year-over-year, fell short of expectations by $0.58 million, reflecting challenges in market demand that could impact future growth outlook.
Slight Operating Income Increase: Operating income rose 1.0% to $23.4 million in Q1, demonstrating the company's efforts in cost control and efficiency improvements, although the growth rate remains modest.
Stable Adjusted Operating Income: Adjusted operating income for Q1 remained flat at $25.8 million compared to the same period last year, indicating stability in profitability but a lack of significant growth momentum.